Exemestane and Increased tendency to bruise - a phase IV clinical study of FDA data

Summary:

Increased tendency to bruise is reported only by a few people who take Exemestane.

The phase IV clinical study analyzes which people take Exemestane and have Increased tendency to bruise. It is created by eHealthMe based on reports of 10,196 people who have side effects while taking Exemestane from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 22, 2022

10,196 people reported to have side effects when taking Exemestane.
Among them, 5 people (0.05%) have Increased tendency to bruise.


What is Exemestane?

Exemestane has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 10,325 Exemestane users for its effectiveness, alternative drugs and more.

What is Increased tendency to bruise?

Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone) is found to be associated with 1,187 drugs and 708 conditions by eHealthMe.

Number of Exemestane and Increased tendency to bruise reports submitted per year:

Could Exemestane cause Increased tendency to bruise?

Gender of people who have Increased tendency to bruise when taking Exemestane *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Increased tendency to bruise when taking Exemestane *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 66.67 %

Common drugs people take besides Exemestane *:

  1. Remicade: 2 people, 40.00%
  2. Pantoprazole Sodium: 2 people, 40.00%
  3. Methotrexate: 2 people, 40.00%
  4. Ibrance: 2 people, 40.00%
  5. Zopiclone: 1 person, 20.00%
  6. Prolia: 1 person, 20.00%
  7. Imitrex: 1 person, 20.00%

Common side effects people have besides Increased tendency to bruise *:

  1. Fatigue (feeling of tiredness): 4 people, 80.00%
  2. Insomnia (sleeplessness): 4 people, 80.00%
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 60.00%
  4. Muscle Aches (muscle pain): 3 people, 60.00%
  5. Nosebleed (bleeding from nose): 2 people, 40.00%
  6. Breathing Difficulty: 2 people, 40.00%
  7. Cough: 2 people, 40.00%
  8. Hyperhidrosis (abnormally increased sweating): 2 people, 40.00%
  9. Headache (pain in head): 2 people, 40.00%
  10. High Blood Pressure: 2 people, 40.00%

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 40.00%
  2. Hormone Level Abnormal: 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Exemestane and have Increased tendency to bruise?

Check whether Increased tendency to bruise is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Exemestane:

Increased tendency to bruise treatments and more:

COVID vaccines that are related to Increased tendency to bruise:

How severe was Increased tendency to bruise and when was it recovered:

Expand to all the drugs that have ingredients of exemestane:

Common drugs associated with Increased tendency to bruise:

All the drugs that are associated with Increased tendency to bruise:

Common conditions associated with Increased tendency to bruise:

All the conditions that are associated with Increased tendency to bruise:

How the study uses the data?

The study uses data from the FDA. It is based on exemestane (the active ingredients of Exemestane) and Exemestane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: